METabolic PROFILE of Hepatocarcinoma and Pancreatic Tumors
This study is about liver cancer (hepatocellular carcinoma) and pancreatic cancers (pancreatic adenocarcinoma and neuroendocrine tumors). These are serious health challenges made complex because each person's cancer can behave differently. Current tests don't always capture these differences well enough. Researchers believe cancer cells have unique ways of getting energy to grow. By studying these "metabolic profiles" — how cancer cells use nutrients — they hope to find new, more accurate markers. These markers could help doctors predict how a cancer might behave and choose the best treatments. The project aims to see if these unique cancer fingerprints can be found early using small tissue samples or blood tests, leading to better, more personalised care.
At a glance
What is this study about?
This research focuses on two main types of cancer: liver cancer (known as hepatocellular carcinoma) and pancreatic cancers (specifically pancreatic adenocarcinoma and pancreatic neuroendocrine tumors). These are common and serious conditions that affect many people. While doctors have ways to treat them, the current methods don't always fully account for how different these cancers can be from person to person. This means that a treatment that works well for one person might not be as effective for another, even with the same type of cancer.
The scientists in this study are exploring a new idea: that cancer cells use energy and nutrients in different ways compared to healthy cells. Imagine cancer cells as having a unique "diet" or "fuel source" that helps them grow and spread. By understanding these specific energy pathways, researchers hope to identify unique patterns, or "signatures," that are specific to these cancers. They've already done some early checks on tissue samples that suggest these unique patterns exist.
The main goal of this study is to confirm if these unique cancer signatures can be found early on. They're looking at different types of samples, including small tissue biopsies and even blood samples. If successful, finding these specific markers could help doctors better understand a patient's cancer, predict how it might develop, and choose the most effective and personalized treatments. This could lead to much improved care for people with liver and pancreatic cancers in the future.
Key takeaways
- The study explores new ways to understand liver and pancreatic cancers.
- It focuses on how cancer cells use energy to grow differently from healthy cells.
- Researchers hope to find unique 'fingerprints' of these cancers.
- These 'fingerprints' could lead to better, more personalised treatments.
- The study will use small tissue biopsies and/or blood samples to find these markers.
Who may be eligible?
To join this study, you need to be at least 18 years old and have signed a form agreeing to take part. You also need to be covered by a social security plan.
For liver cancer, you might be able to join if you have hepatocellular carcinoma that can be treated with surgery (like removing part of the liver or a liver transplant) and don't need treatment before surgery. You could also be eligible if your liver cancer isn't suitable for surgery or other curative treatments.
For pancreatic cancer, you might be able to join if you have pancreatic adenocarcinoma or a pancreatic neuroendocrine tumor that can be treated with surgery, even if you need treatment before the operation. You could also be eligible if your pancreatic cancer can't be removed by surgery and you're planning to have medical treatment only.
Could this study suit you?
Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.
- Are you 18 years or older?
- Do you have hepatocellular carcinoma, pancreatic adenocarcinoma, or a pancreatic neuroendocrine tumor?
- Are you able to provide your informed consent to participate?
- Are you covered by a social security healthcare plan?
- Are you not currently pregnant or breastfeeding?
What does participation involve?
This section of the study information isn't fully detailed in the provided text, so we can't give a complete picture of what taking part involves. However, based on the summary, it will likely involve providing tissue samples, such as biopsies, and possibly blood samples. The study aims to identify specific markers from these samples. You would likely need to continue with your planned medical care for your liver or pancreatic condition. There isn't information about specific visits, medication, or follow-up duration beyond this. Always discuss the full commitment with your doctor.
Potential risks and benefits
Locations (1)
- Hôpital BeaujonVerified postcodeClichy, France· Recruiting
Common questions
What types of cancer is this study looking at?
This study is looking at liver cancer (hepatocellular carcinoma) and two types of pancreatic cancer (pancreatic adenocarcinoma and pancreatic neuroendocrine tumors).
What is the main goal of this research?
The main goal is to find new ways to understand how these cancers grow by studying their unique energy needs, which could lead to better tests and treatments.
Will I get direct benefit from joining this study?
Joining this study may not directly benefit you, but the information learned could help others in the future.
What types of samples might be taken?
The study will likely involve taking small tissue samples (biopsies) and/or blood samples.
Can I leave the study if I change my mind?
Yes, you can leave the study at any time without it affecting your medical care.
How to find out more
Valérie Paradis, MD, PhD
Always speak to your GP or specialist before deciding to take part in a study.
Interested in taking part?
Discussion
Community discussion
Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.